Sign in

CIK 0001671858

  • Non-accelerated filer
  • Smaller reporting company

ARS Pharmaceuticals, Inc.

Sign in to watch
Ticker
SPRY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811489190
Phone
+1 858-771-9307
Business address
11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
Former names
Silverback Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-05-17 Lowenthal Richard E President and CEO Gift −1,050,000 4,126,822
2023-05-17 Lowenthal Richard E President and CEO Gift +1,050,000 1,050,000
2023-05-17 Lowenthal Richard E President and CEO Gift −1,050,000 3,276,854
2023-05-17 Lowenthal Richard E President and CEO Gift +1,050,000 2,100,000
2023-05-17 Tanimoto Sarina Chief Medical Officer Gift −1,050,000 3,276,854
2023-05-17 Tanimoto Sarina Chief Medical Officer Gift +1,050,000 1,050,000
2023-05-17 Tanimoto Sarina Chief Medical Officer Gift −1,050,000 4,126,822
2023-05-17 Tanimoto Sarina Chief Medical Officer Gift +1,050,000 2,100,000
2023-05-09 Shawver Laura Director Exercise or conversion 10b5-1 +42,900 $1.27 $54K 253,246
2023-05-09 Shawver Laura Director Sale 10b5-1 −42,900 $5.31 $228K 210,346
2023-05-09 Shawver Laura Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −42,900 302,997
2023-05-08 Shawver Laura Director Exercise or conversion 10b5-1 +57,100 $1.27 $73K 267,446
2023-05-08 Shawver Laura Director Sale 10b5-1 −57,100 $6.16 $352K 210,346
2023-05-08 Shawver Laura Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −57,100 345,897
2023-01-03 Scott Kathleen D. Chief Financial Officer Grant or award · Stock option (right to buy) +50,000 50,000
2023-01-03 Fitzpatrick Alexander A Chief Legal Officer Grant or award · Stock option (right to buy) +700,000 700,000
2023-01-03 Chakma Justin Chief Business Officer Grant or award · Stock option (right to buy) +165,000 165,000
2023-01-03 Karas Eric Chief Commercial Officer Grant or award · Stock option (right to buy) +50,000 50,000
2023-01-03 Tanimoto Sarina Chief Medical Officer Grant or award · Stock option (right to buy) +350,000 350,000
2023-01-03 Tanimoto Sarina Chief Medical Officer Grant or award · Stock option (right to buy) +1,100,000 1,100,000

Page 23 of 31 · 602 trades